Get Articles Daily from StraightStocks - Enter Email Address


  • National Debt Clock


Cytori Therapeutics (CYTX)Announces Sale of First EU StemSource Bank

Posted on Monday, July 14th, 2008 | In Current Market News
Contributed by: Mike Havrilla (http://mikehav.blogspot.com/) -

Cytori Therapeutics (Nasdaq: CYTX) 1-Year Chart

Cytori Therapeutics (CYTX) announced its first European Union sale of the StemSource Cell Bank as part of an exclusive licensing agreement with Biohellenika in Greece, which is one of the largest markets for cell banking in Europe. The StemSource Cell Bank is based on the Celution 900 System, which has the ability to process and store stem/regnerative cells derived from fat tissue for future use. Shares of Cytori are currently trading up 3.5% today at the $6/share level on volume of about 23,000 shares as of 12 noon. The StemSource Cell Bank is also being marketed exclusively by Green Hospital Supply in select Asian countries and directly by Cytori in Europe and the Middle East.

Last 5 posts by Mike Havrilla

Tags for this Post:
Current Market News




About Mike Havrilla (http://mikehav.blogspot.com/)

The MikeHav Market Blog provides investors with a free source of stock profiles, tools, and commentaries focused on
carbon credits, the healthcare sector, exchange-traded funds (ETFs), and innovative companies across all industries.

I am a pharmacist and index developer who has been investing since August 1997 and freelance writing for investors since April 2007. I am also an avid runner since 1992 and have completed 18 marathons (26.2 miles) with a personal best time of 2 hours, 54 minutes.

I can be contacted via email at mikehavrx[at]yahoo[dot]com.

MikeHav Market Blog: www.mikehav.blogspot.com

MikeHav Market Blog RSS Feed: http://feedproxy.google.com/mikehavblog

Investment Web Domain Names [PDF]: www.geocities.com/mikehavrx/websites.pdf

Global Carbon Trading Index [PDF]: www.geocities.com/mikehavrx/ctindex.pdf

Leave a Reply

Name

Email (kept private)

Website









No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.